The ICOD (Improving Condition in Down syndrome) project, a pioneering study in addressing the cognitive difficulties associated with Down syndrome, has demonstrated the safety of treatment with the molecule AEF0217, developed by the French biotech Aelis Farma, as well as its effectiveness in improving cognitive function in these people.
The biotech news you need from the weekend
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hi there. Today, we